Get ready to mark your calendars because the much anticipated third quarter financial results of MacroGenics (NASDAQ: MGNX) are set to be unveiled on Tuesday 5th November 2024. Investors and market watchers will have the chance to dive into the company's financial performance as the announcement is scheduled after market close.
In accordance with the predictions of financial analysts on Wall Street, the organization is on track to report an expected per share of $0.21 profit for the quarter. Furthermore, the firm is projected to disclose a total revenue of $76.11 million for this quarter.
Financial analysts have shared their forecasts for the company's annual performance, indicating their belief that the company will achieve a total revenue of $121.04 million. Additionally, they predict that the earnings per share for the company will hit loss of $2.01 by the end of the fiscal year.
Upon revisiting the corresponding quarter from the prior year, the company's earnings report demonstrated a per-share income of $0.28. This figure was attributed to the company's total revenue, which reached an impressive $10.4 million during that same period.
Additionally, The company will host a conference call with investors and analysts on 5th November 2024 at 04:30 PM eastern time to review the Q3 2024 financial results.
The previous trading day saw MacroGenics (MGNX) shares trading between $3.66 and $3.95, besides a volume of 479.10 thousand shares. The stock closed Friday's regular trading session at $3.87, indicating 5.74 percent upturn.
